BeiGene is a global scientific biotechnology company specializing in the creation of innovative and inexpensive drugs to improve treatment outcomes available to patients around the world. With a portfolio of more than 40 clinical candidates, the company accelerates the development of a portfolio of therapeutic drugs through its own development and partnership with other companies.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |